The use of long-acting bronchodilators to treat asthma had no impact for some African-American children, according to a new study from Ann & Robert H. Lurie Children’s Hospital of Chicago and the Department of Pediatrics.
A new study has found that a particularly deadly form of pediatric brain tumor may have a weakness that could inspire future treatments.
Thomas Shanley, MD, chair of Pediatrics, has been named as nominee for election as President and CEO of Ann & Robert H. Lurie Children’s Hospital of Chicago.
Northwestern Medicine scientists have discovered that the protein FMRP — the loss of which leads to Fragile X syndrome — is a novel reader of RNA methylation.
Many patients with mild asthma may not benefit from inhaled steroid medications, the current standard treatment, according to a clinical trial published in the New England Journal of Medicine.
In a new clinical exposure program, doctoral students in the Driskill Graduate Program in Life Sciences partner with clinicians at Lurie Children’s Hospital to forge connections between basic and clinical research efforts.
Cholesterol levels in U.S. youth have improved from 1999 to 2016, but only half of children and adolescents are in the ideal range, according to a new study published in JAMA.
Visitor restrictions during winter months were associated with a significant decrease in the transmission of viral respiratory infections among hospitalized children, according to a Northwestern study.
A team of scientists has identified new genetic regions associated with asthma in people of African ancestry, according to a study published in Nature Communications.
Feinberg investigators are conducting basic science research, epidemiological studies and drug trials of new therapies for food allergies to uncover the breadth of the problem, understand the basic cellular pathways and develop new avenues of treatment.